麦角新碱治疗期间的胸腔积液和纤维化
Pleural effusion and fibrosis during treatment with methysergide.
作者信息
Hindle W, Posner E, Sweetnam M T, Tan R S
出版信息
Br Med J. 1970 Mar 7;1(5696):605-6. doi: 10.1136/bmj.1.5696.605.
Abstract
Two patients being treated for migraine with methysergide developed extensive pleural fibrosis, and in addition one of them had bilateral pleural effusions, After treatment was stopped these complications, which are thought to have been due to the drug, cleared in the next few months.
摘要
两名使用麦角新碱治疗偏头痛的患者出现了广泛的胸膜纤维化，此外其中一人还有双侧胸腔积液。在停止治疗后，这些被认为是由药物引起的并发症在接下来的几个月内消退了。
相似文献
1
Pleural effusion and fibrosis during treatment with methysergide.麦角新碱治疗期间的胸腔积液和纤维化
Br Med J. 1970 Mar 7;1(5696):605-6. doi: 10.1136/bmj.1.5696.605.
2
Pleural effusion and fibrosis secondary to Sansert administration.服用麦角乙脲后引发的胸腔积液和纤维化。
Ann Thorac Surg. 1973 Mar;15(3):295-8. doi: 10.1016/s0003-4975(10)65302-7.
3
Pleural thickening caused by Sansert and Ergotrate in the treatment of migraine.在偏头痛治疗中，麦角胺咖啡因和麦角新碱引起的胸膜增厚。
AJR Am J Roentgenol. 1980 Aug;135(2):375-7. doi: 10.2214/ajr.135.2.375.
4
Cardiac and pulmonary fibrosis during methysergide therapy for headache.麦角新碱治疗头痛期间的心脏和肺部纤维化
Trans Am Clin Climatol Assoc. 1967;78:79-92.
5
[Pleurisy and pleural fibrosis developing during treatment with methysergide].[麦角新碱治疗期间发生的胸膜炎和胸膜纤维化]
Nord Med. 1968 May 23;79(21):681-4.
6
[Letter: Pleuropulmonary fibrosis due to methysergide with circulating immune complexes[].[信件：麦角酰二乙胺导致的胸膜肺纤维化伴循环免疫复合物[]。
Nouv Presse Med. 1975 Nov 15;4(39):2809.
7
A 47 year old man with nonproductive cough and right-sided chest pain.一名47岁男性，有干咳及右侧胸痛症状。
Eur Respir J. 1997 Sep;10(9):2171-3. doi: 10.1183/09031936.97.10092173.
8
[Pleuro-pulmonary fibrosis caused by methysergide].[麦角新碱引起的胸膜肺纤维化]
Sem Hop Ther. 1976 Jan;52(1):9-13.
9
[Pleuro-pulmonary fibrosis caused by methysergide].[麦角新碱引起的胸膜-肺纤维化]
Nouv Presse Med. 1981 Jul 4;10(29):2440-1.
10
Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
Respir Med. 1998 Sep;92(9):1172-4. doi: 10.1016/s0954-6111(98)90415-2.
引用本文的文献
1
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.帕金森病治疗的最新进展：溴隐亭的作用
J Neural Transm. 1981;51(1-2):175-84. doi: 10.1007/BF01664014.
2
Progressive leptomeningeal fibrosis: a clinico-pathological case report.进行性软脑膜纤维化：一例临床病理病例报告
J Neurol Neurosurg Psychiatry. 1983 Mar;46(3):261-5. doi: 10.1136/jnnp.46.3.261.
3
Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene.丹曲林治疗后出现的肺炎、胸腔积液和心包炎。
J Neurol Neurosurg Psychiatry. 1984 May;47(5):553-4. doi: 10.1136/jnnp.47.5.553.
4
Bromocriptine induced pleuropulmonary fibrosis.溴隐亭诱发胸膜肺纤维化。
Thorax. 1986 Apr;41(4):328-30. doi: 10.1136/thx.41.4.328.
本文引用的文献
1
METHYSERGIDE AS A SUPPRESSANT OF MIGRAINE ATTACKS.甲基麦角新碱作为偏头痛发作的抑制剂
Practitioner. 1964 Dec;193:792-5.
2
Acute ischemia of a limb complicating methysergide maleate therapy.马来酸美西麦角治疗引发的肢体急性缺血。
JAMA. 1963 Mar 23;183:1041-2. doi: 10.1001/jama.1963.63700120038017b.
3
Cardiac and pulmonary fibrosis during methysergide therapy for headache.麦角新碱治疗头痛期间的心脏和肺部纤维化
Am J Med Sci. 1967 Jul;254(1):1-12. doi: 10.1097/00000441-196707000-00001.
4
Fibrotic disorders associated with methysergide therapy for headache.与用于治疗头痛的美西麦角疗法相关的纤维化疾病。
N Engl J Med. 1966 Feb 17;274(7):359-68. doi: 10.1056/NEJM196602172740701.
5
[Pleurisy and pleural fibrosis developing during treatment with methysergide].[麦角新碱治疗期间发生的胸膜炎和胸膜纤维化]
Nord Med. 1968 May 23;79(21):681-4.
Zotero 插件